ECLEcolab, Inc. — stock analysis & sentiment
Ecolab, Inc. (ECL) last closed at $286.98, in the upper half of its 52-week range of $243.15–$309.27. Composite market sentiment across 1 analysis is positive (+37 on a −100 to +100 scale), as of Aug 25, 2026.
Produced by the Synoptiv Research Engine from public financial data. Read the methodology.
Go beyond the overview
The thesis, technical signals, risk levels, and complete evidence — everything the overview leaves out.
What the data says
An overview of the public data behind ECL.
At a last close of $286.98, the stock sits in the upper part of a 52-week band that runs from $243.15 to $309.27 — a spread of roughly 27% from low to high, which is a fairly contained year for a company of this size. The price is closer to the top of that range than the bottom, and with a beta of 0.89 the shares have tended to move slightly less than the broad market rather than amplifying it.
The market is paying about 38 times trailing earnings and roughly 30 times forward estimates for that ~$80 billion capitalization, alongside close to 8 times book value — multiples well above where the average industrial or materials name trades, and the gap between the trailing and forward figures reflects expectations of earnings growth ahead. The underlying business converts about 12.6% of revenue into profit and grew revenue near 10%, so the premium rests on steady mid-single to high-single-digit expansion and consistent margins rather than rapid growth. The dividend adds just over 1% a year, making income a modest part of the total return here.
News flow over the past several months has been split between company-specific items and broader sector coverage. The two direct headlines were the $4.75 billion acquisition of CoolIT, which pushes the company into cooling for AI data centers, and a fourth-quarter report where earnings and revenue came in slightly ahead of estimates and the shares rose. The remainder — pieces on medical device cleaning, sustainable paper chemicals, sectors holding up in a choppy market, and stock lists tied to the AI buildout — is industry and market commentary in which the company appears as one name among many, not the subject.
Written from public market data. Research, not financial advice — the thesis, signals and risk levels are in the full report.
Price chart
ECL daily price history.
Market sentiment
A composite of the public market data in this analysis, from −100 (bearish) to +100 (bullish).
This gauge blends news tone, analyst views, insider and congressional activity, and price momentum into a single score. The full report breaks down each driver and pairs it with the thesis.
See the full sentiment breakdown in the report →Key stats
A public snapshot of commonly used market and valuation measures.
Valuation & size
- Market cap
- $79.96B
- Enterprise value
- $89.26B
- P/E (TTM)
- 38.24
- Forward P/E
- 30.29
- Price / book
- 7.95
- Price / sales
- 4.75
Profitability & growth
- Net margin
- 12.57%
- Revenue growth
- +9.70%
- Earnings growth
- +3.30%
- Dividend yield
- 1.02%
Price & risk
- Beta
- 0.89
- Average volume
- 1.55M
From noise to signal. The full report has ECL’s thesis, trade signal, and risk levels.
About Ecolab, Inc.
Ecolab Inc. is a Saint Paul, Minnesota-based provider of water treatment, hygiene, and infection prevention products and services, operating in the United States and internationally. Founded in 1923, the company reports through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Water segment serves industrial customers — including food and beverage processing, chemicals, mining and primary metals, power generation, refining, petrochemicals, and pulp and paper — with water treatment, process applications, and cleaning and sanitizing solutions. The Institutional & Specialty segment supplies cleaning and sanitizing products to foodservice, healthcare, hospitality, government, education, and retail customers, while Global Pest Elimination handles rodent and insect control for restaurants, food processors, hotels, grocers, and similar operations. Global Life Sciences provides cleaning and contamination control for pharmaceutical and personal care manufacturing. Products reach customers through a field sales force, corporate account teams, distributors, and dealers, under brands including Ecolab, Kay, Purolite, and Bioquell.
Latest news
Recent headlines related to ECL, with vendor tone.
ECL — frequently asked questions
Answered from the public data on this page.
What is the current market sentiment for ECL?
As of Aug 25, 2026, Ecolab, Inc. (ECL) carries positive (+37 on a −100 to +100 scale) composite sentiment. The score fuses recent news tone, analyst recommendations, technical posture, insider and congressional activity, and market attention into a single figure. The full breakdown of each component is in the report.
How has ECL stock been performing?
Ecolab, Inc. last closed at $286.98, in the upper half of its 52-week range of $243.15–$309.27.
What is ECL's market cap and valuation?
Ecolab, Inc. has a market capitalization of about $79.96B, a trailing P/E of 38.2, a dividend yield of 1.02%.
What sector is ECL in, and who are its competitors?
Ecolab, Inc. operates in the Basic Materials sector, specifically Specialty Chemicals. Comparable companies include SHW, PPG, IFF, DD, ALB.
Where can I find a full analysis of ECL?
The full ECL report covers the bull and bear cases, technical signals with entry, stop and target levels, complete financial statements, earnings history, insider and congressional trades, and the conditions that would invalidate the thesis. It requires a free account.
Analysis history
Every saved analysis, newest first.